Literature DB >> 18071103

Treatment of catatonia with olanzapine and amantadine.

Parker W Babington1, David R Spiegel.   

Abstract

Catatonia is a disorder characterized by mutism, posturing, echophenomena, and negativism. The preferred treatment for non-malignant catatonia is benzodiazepines, which often produce a reduction in symptoms within 24 hours. Presented here is a case report of a 19-year-old woman appearing in a catatonic state that did not respond to lorazepam. On the basis of emerging evidence that atypical antipsychotics and weak N-Methyl-D-Aspartate (NMDA) receptor-antagonists may effectively treat catatonia, we treated our patient with olanzapine and amantadine, which resulted in a dramatic reduction in her catatonic symptoms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18071103     DOI: 10.1176/appi.psy.48.6.534

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  7 in total

Review 1.  [Pharmacotherapy of psychiatric acute and emergency situations: General principles].

Authors:  T Messer; F-G Pajonk; M J Müller
Journal:  Nervenarzt       Date:  2015-09       Impact factor: 1.214

Review 2.  [Psychopharmacotherapy in emergency medicine].

Authors:  A Wolf; M J Müller; F-G B Pajonk
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-11       Impact factor: 0.840

Review 3.  A clinical review of the treatment of catatonia.

Authors:  Pascal Sienaert; Dirk M Dhossche; Davy Vancampfort; Marc De Hert; Gábor Gazdag
Journal:  Front Psychiatry       Date:  2014-12-09       Impact factor: 4.157

4.  Acute catatonia on medical wards: a case series.

Authors:  Elisabeth Doran; John D Sheehan
Journal:  J Med Case Rep       Date:  2018-07-06

5.  First known case of catatonia due to cyclosporine A-related neurotoxicity in a pediatric patient with steroid-resistant nephrotic syndrome.

Authors:  R David Heekin; Kalonda Bradshaw; Chadi A Calarge
Journal:  BMC Psychiatry       Date:  2019-04-24       Impact factor: 3.630

Review 6.  Molecular and cellular mechanisms leading to catatonia: an integrative approach from clinical and preclinical evidence.

Authors:  Daniel Felipe Ariza-Salamanca; María Gabriela Corrales-Hernández; María José Pachón-Londoño; Isabella Hernández-Duarte
Journal:  Front Mol Neurosci       Date:  2022-09-29       Impact factor: 6.261

7.  Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? A case series of 39 patients.

Authors:  Bunta Yoshimura; Tomoya Hirota; Manabu Takaki; Yoshiki Kishi
Journal:  Neuropsychiatr Dis Treat       Date:  2013-10-10       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.